Gyon Technologies Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,725	Closed	-$232K	–	463
2021 Q4	$232K	Buy	+2,725	New	+$232K	0.04%	473
2021 Q3	–	Sell	-3,628	Closed	-$353K	–	450
2021 Q2	$353K	Buy	+3,628	New	+$353K	0.12%	243